| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.32 | 0.04 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.077 | 0.04 |